Gerald Villanueva

Gerald Villanueva

Auto-generated profile, based on publicly available information

Gerald Villanueva

Department of Gastroenterology, New York University School of Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
JCJonathan Cohen
Jonathan Cohen
SCSeth A. Cohen
Seth A. Cohen
KVKinjal C. Vora
Kinjal C. Vora
XXXiaonan Xue
Xiaonan Xue
JBJ. Steven Burdick
J. Steven Burdick
GVGerald Villanueva
Gerald Villanueva

8 June 2012 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
SHSpiros P Hiotis
Spiros P Hiotis
NRNuh N Rahbari
Nuh N Rahbari
GVGerald A Villanueva
Gerald A Villanueva
EKEunjie Klegar
Eunjie Klegar
WLWei Luan
Wei Luan
HYHerman T Yee
Herman T Yee
To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection.

1 July 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NCNoami Chaudhary
Noami Chaudhary
CLCatherine Lucero
Catherine Lucero
GVGerald Villanueva
Gerald Villanueva
MPMichael Poles
Michael Poles
CGColleen Gillespie
Colleen Gillespie
EWElizabeth Weinshel
Elizabeth Weinshel

9 January 2012 in Journal of Digestive Diseases
Verified
Journal Article
Open access
PDF file
QWQin Wang
Qin Wang
WLWei Luan
Wei Luan
GVGerald A. Villanueva
Gerald A. Villanueva
NRNuh N. Rahbari
Nuh N. Rahbari
HYHerman T. Yee
Herman T. Yee
SHSpiros P Hiotis
Spiros P Hiotis
OBJECTIVE: The aim of this study was to determine the impact of hepatocelluar carcinoma (HCC) screening in chronic hepatitis B patients who did not meet the current screening recommendations. METHODS: Patients who were admitted to Bellevue Hospital Center with HCC were assessed for risk factors, cirrhosis and tumor-specific factors. Eligibility for liver transplantation or resection with favorable outcome was determined by applying Milan criteria. RESULTS: In all 93 patients were diagnosed with hepatitis B virus (HBV)-associated HCC, 18 of whom were under 40 years. Cirrhosis was infrequently associated with HCC in this group, with most cancers occurring in non-cirrhotic patients (12/18, 66.7%). No patient developed HCC outside the American Association for the Study of Liver Diseases (AASLD) cancer screening recommendations (young age, non-cirrhotic) were eligible for liver transplantation or resection with favorable outcomes (within Milan criteria). However, HCC patients who were diagnosed within AASLD screening recommendations did meet Milan criteria in 17.3% (14/81) patients. CONCLUSIONS: Current guidelines for HCC screening in patients with HBV may lead to a delay in diagnosis in non-cirrhotic patients under 40 years. Consideration should be given to modifying current recommendations to advocate entering HBV patients into a cancer-screening program at young age.

1 September 2010 in HPB Surgery
Verified
Journal Article
Open access
PDF file
ZAZeinab Abdi
Zeinab Abdi
SKSvetlana Krasnokutsky
Svetlana Krasnokutsky
ARAmy Rapkiewicz
Amy Rapkiewicz
ASAmit Saxena
Amit Saxena
GVGerald Villanueva
Gerald Villanueva
USUmut Sarpel
Umut Sarpel
Background. The hepatitis C virus is a major cause of hepatocellular carcinoma. Extrahepatic manifestations of hepatitis C include mixed cryoglobulinemia which can result in ischemic damage to multiple organs. The management of these sequelae in posthepatectomy patients is unclear. Case Report. A 49-year-old male with hepatitis C was found to have a 4 cm hepatocellular carcinoma on surveillance imaging. He underwent portal vein embolization followed by hepatectomy. His postoperative course was complicated by the development of splenic infarcts, small bowel ischemia, skin lesions, and liver damage. Findings of elevated cryocrit and elevated rheumatoid factor suggested the diagnosis of cryoglobulin-related vasculitis. The patient improved on supportive care. Conclusion. Cryoglobulinemia is associated with hepatitis C and may complicate the care of this patient population. The treatment of cryoglobulinemia posthepatectomy patients is complicated by concerns over how medications may affect the regenerating liver. Steroids should be used with caution in this setting. Summary. Brief report of hepatectomy complicated by vasculitis in the context of hepatocellular carcinoma secondary to hepatitis C addresses the management of mixed cryoglobulinemia in post-hepatectomy patients.

11 January 2014 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
NSNagashree Seetharamu
Nagashree Seetharamu
JMJonathan Melamed
Jonathan Melamed
GMGeorge Miller
George Miller
HRHeidrun Rotterdam
Heidrun Rotterdam
TGTamas Gonda
Tamas Gonda
BHBalazs Halmos
Balazs Halmos